Cipher Pharmaceuticals Inc.
2 clinical trials · Sponsor
◉ Watch Cipher Pharmaceuticals Inc.
| Record | Firm | Date |
|---|---|---|
| PK and Safety Study of Natroba Topical Suspension 0.9% in Subjects 1 Month to 3 Years 11 Months of Age With Scabies (NCT05310734) | Cipher Pharmaceuticals Inc. | 2022-03-04 |
| Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne (NCT00975143) | Cipher Pharmaceuticals Inc. | 2009-09-01 |
Track Cipher Pharmaceuticals Inc. automatically
Every clearance here is in the API, with alerts when new ones post.